Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 20th, 2023%
Data from three health repositories show a simple blood test reveals inherited and acquired genetic indicators, analyzed with artificial intelligence, to detect coronary heart disease. . . . → Read More: A.I. Analytics Show Blood Test Detects Heart Disease
By Alan, on September 28th, 2023%
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks. . . . → Read More: Cardiac Tech Start-Up Partners with Mayo Clinic
By Alan, on July 31st, 2023%
A system using deep learning algorithms to analyze ultrasound video images is shown to detect a difficult-to diagnose type of heart failure with clips from one view of the heart. . . . → Read More: A.I. Analytics Detect Heart Failure in Single Ultrasound View
By Alan, on January 11th, 2023%
A new company developing techniques to analyze internal physiological sounds captured by stethoscopes as health indicators is raising $3.7 million in seed funds. . . . → Read More: Audio Digital Biomarkers Start-Up Raises $3.7M in Seed Funds
By Alan, on December 6th, 2022%
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System
By Alan, on September 14th, 2022%
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds
By Alan, on August 30th, 2022%
A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat. . . . → Read More: Trial to Test Smart Watch to Guide Blood Thinners
By Alan, on August 3rd, 2022%
Tests with lab monkeys show a vaccine with a synthetic peptide lowers so-called bad cholesterol in blood for longer periods than a comparable monoclonal antibody. . . . → Read More: Peptide Vaccine Shown to Reduce Harmful Cholesterol
By Alan, on July 12th, 2022%
A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease. . . . → Read More: Trial Begins of Precise Gene Editing for Heart Disease
By Alan, on March 31st, 2022%
A biotechnology company discovering new drugs based on animal genomics is partnering with a university lab on research in mammal hibernation and adaption. . . . → Read More: Biotech, University Partner on Mammal Hibernation Genomics
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|